Abstract
Clinical: Accounts for nearly 10–20 % of all pemphigus cases. It presents typically during midlife as recurrent crops of easily ruptured vesicles or pustules involving the head, neck and upper trunk, rarely involving mucosal membranes (often due to unaffected residual presence of desmoglein 3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Bernard P, Antonicelli F, Bedane C, Joly P, Le Roux-Villet C, Duvert-Lehembre S, Rousselle P, Prost-Squarcioni C. Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol. 2013;20:1–8.
Chimanovitch I, Hamm H, Georgi M, Kroiss M, Stolz W, Apitz C, Bröcker EB, Zillikens D. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood. Arch Dermatol. 2000;136(4):527–32.
Amagai M, Stanley JR. Desmoglein as a target in skin disease and beyond. J Invest Dermatol. 2012;132(3 Pt 2):776–84. doi:10.1038/jid.2011.390.
Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381(9863):320–32. doi:10.1016/S0140-6736(12)61140-4.
Fortuna G, Marinkovich MP. Linear immunoglobulin A bullous dermatosis. Clin Dermatol. 2012;30(1):38–50.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Cockerell, C., Mihm, M.C., Hall, B.J., Chisholm, C., Jessup, C., Merola, M. (2014). Vesiculobullous Diseases. In: Dermatopathology. Springer, London. https://doi.org/10.1007/978-1-4471-5448-8_4
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5448-8_4
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5447-1
Online ISBN: 978-1-4471-5448-8
eBook Packages: MedicineMedicine (R0)